CBUS NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Cibus Global LLC · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 1.93 USD
13.5% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 0.9% above the Trend Line and sits at 27.1% of its 52-week range. The latest completed week returned 13.5%, after a 38.8% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bearish with 37/100 conviction, while the latest news-sentiment score is 48/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 44 out of 100
Latest Close 1.93 USD 31 Jul 2026
1W Return 13.5% latest completed week
4W Return 38.8% short-term follow-through
12W Return 34.0% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 13.5% Latest completed week; four-week move 38.8%. Indicator stack 16/75 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 37/100 conviction; expected move 44.1%. News sentiment 48/100 65 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 0.9% above the Trend Line and sits at 27.1% of its 52-week range. The latest completed week returned 13.5%, after a 38.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1212-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 38.8% over four weeks, 34.0% over 12 weeks, and 29.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W13.5%
4W38.8%
12W34.0%
26W-1.0%
52W29.5%
Active trend streak0 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.65Latest activity-pressure read.
Pressure change169.6%Four-week change in activity pressure.
Leadership1.78Latest relative-leadership reading.
RS change106.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 79% Model confidence 76%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength6/100Blend of value, momentum, and quality. Underlying universe rank 95; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality9/100Profitability and accounting quality. Underlying universe rank 92; rank 1 is best.
Momentum26/100Medium-term price momentum. Underlying universe rank 75; rank 1 is best.
Growth18/100Revenue and earnings growth. Underlying universe rank 83; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
30.3x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-13.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
72.1%
Gross profit retained from each unit of revenue.
Operating margin
-1581.8%
Operating profit retained from revenue.
Free-cash-flow margin
-1163.0%
Free cash flow generated from revenue.
Return on invested capital
-18.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-9.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-49.9%
Net share repurchases relative to market value.
Shareholder yield
-49.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-3.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

CBUS shows bearish options pressure with a 37/100 conviction score, put-call volume ratio of 1.90, expected move of 44.1%, and Sharemaestro trend signal inactive.

Conviction37/100
Expected move44.1%
Put/call volume1.90
Pressure-19
Speculation3
Volatility49
Trend agreement92
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment48/100

Weighted news tone is neutral across 65 relevant articles.

10 positive · 39 neutral · 16 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move44.1%Nearest-chain priced movement where available.
52-week drawdown-53.9%Distance below the 52-week high.
13-week volatility14.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+45.3%Week of 10 Jul.
Worst week-34.6%Week of 20 Mar.
Latest week+13.5%Week of 31 Jul.

Shape of recent returns

Strong gains12
Modest gains1
Flat weeks1
Modest losses2
Sharp losses10
Recent vol14.3%13-week weekly-return volatility.
Base vol13.4%52-week weekly-return volatility.
Up/down split25/24Count of positive and negative weeks in the 52-week window.
Average skew11.5% / -9.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis19/100

Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 2/12.

Activity pressure 0.12; No reversal markers Factors14/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 96; Small Cap Core rank 88 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options58/100

CBUS shows bearish options pressure with a 37/100 conviction score, put-call volume ratio of 1.90, expected move of 44.1%, and Sharemaestro trend signal inactive.

Bearish · Put-side pressure · Expected move 44.1% Sentiment48/100

Weighted news tone is neutral across 65 relevant articles.

Cibus Inc (CBUS) Financial Health: Profitability & Balance Sheet Analysis Insiders50/100

No recent insider transaction evidence is stored.

 Earnings11d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.93 USD13.5%1.91 USD6.81 USD0.651.78859.5KOff
24 Jul 20261.70 USD-5.0%1.91 USD6.94 USD0.35-9.79622.4KOff
17 Jul 20261.79 USD-11.4%1.91 USD7.05 USD0.04-6.773.9MOff
10 Jul 20262.02 USD45.3%1.91 USD7.15 USD-0.440.534.0MOff
3 Jul 20261.39 USD2.2%1.90 USD7.27 USD-0.93-29.59740.5KOff
26 Jun 20261.36 USD0.0%1.90 USD7.38 USD-1.01-30.921.2MOff
19 Jun 20261.36 USD10.6%1.90 USD7.44 USD-1.02-34.331.5MOff
12 Jun 20261.23 USD-4.7%1.90 USD7.51 USD-1.00-39.451.3MOff
5 Jun 20261.29 USD-10.4%1.90 USD7.61 USD-0.99-35.521.4MOff
29 May 20261.44 USD4.3%1.90 USD7.76 USD-0.97-31.871.2MOff
22 May 20261.38 USD5.3%1.91 USD7.91 USD-0.95-34.701.5MOff
15 May 20261.31 USD-9.0%1.91 USD7.95 USD-0.92-38.49999.9KOff
8 May 20261.44 USD-0.7%1.92 USD8.00 USD-0.85-34.121.8MOff
1 May 20261.45 USD-3.3%1.92 USD8.04 USD-0.70-31.042.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.